DC Fine Chemicals
- Company typePrivate
- Founded2007
- HeadquartersCornellá De Llobregat, Spain
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
DC Fine Chemicals firmographics
Firmographics- Name
- DC Fine Chemicals
- Legal name
- DC FINE CHEMICALS, S.L.
- Website
- https://dcfinechemicals.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Where DC Fine Chemicals is headquartered
LocationHeadquarters
- HQ city
- Cornellá De Llobregat
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
DC Fine Chemicals business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Fine Chemicals Distribution: DC Fine Chemicals distributes fine chemical products for scientific applications including amino acids, analytical reagents, APIs, bile acids, biological buffers, carbohydrates, enzymes, excipients, nucleic acids and derivatives, organic synthesis products, stains and indicators. The company sources products from a global network of suppliers and sells them under their own brand, providing quality control and documentation services.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
DC Fine Chemicals product offering
Product offeringCore offering
DC Fine Chemicals manufactures and supplies a catalogue of 3,000+ reference fine chemical products (including APIs, excipients, amino acids, analytical reagents, bile acids, biological buffers, carbohydrates, enzymes, nucleic acids, organic synthesis intermediates, and stains & indicators) to pharmaceutical, diagnostic, life science, biotech, and industrial customers in 40+ countries. The company sources through a global supplier network giving access to 10,000+ substances and provides in-house quality control, Certificate of Analysis, custom packaging, and OEM services from facilities in Terrassa, Spain and London, United Kingdom.
Product overview
DC Fine Chemicals is a fine chemical manufacturer and supplier operating from facilities in Spain and the United Kingdom. The company offers a portfolio of over 3,000 reference products across 14 product categories, serving four main business areas: Diagnostics (amino acids, antimicrobial agents, bile acids, biological buffers, carbohydrates, enzymes, stains), Life Science (nucleic acids and derivatives, stains), Pharma & Biotech (organic synthesis intermediates, excipients, APIs), and Process Solutions (analytical reagents). Their product range includes amino acids, analytical reagents, antimicrobial products, active pharmaceutical ingredients (APIs), bile acids, biological buffers, carbohydrates, enzymes, excipients, fine chemicals, nucleic acids and derivatives, organic synthesis building blocks, and stains & indicators. The company operates in over 40 countries and emphasizes its role as a reliable partner throughout the development and production process for scientific applications.
Differentiator
Problem solved
Functional benefit
Brands
- PharmaFine®: A product line of pharmaceutical raw materials designed for assessment in parenteral applications, offering greater control for demanding pharmaceutical requirements.
Products and services
- Amino acids Essential elements for cell culture and fermentation processes, used in scientific research and diagnostic applications.
- Analytical reagents Chemical substances for laboratory use, sold in medium and large quantities for analytical applications.
- Antimicrobial products Antimicrobial products for use in culture media and pharmaceutical applications.
- Active Pharmaceutical Ingredients (APIs) Active pharmaceutical ingredients for pharmaceutical applications, including products such as Acetazolamide, Atorvastatin, Azithromycin, Carbamazepine.
- Bile acids Bile compounds for culture media in microbiology applications.
- Biological buffers pH buffer solutions for industrial applications or biology, maintaining stable pH in various processes.
- Carbohydrates Biomolecules composed of carbon, ranging from monosaccharides to polysaccharides, including sugars and starches.
- Enzymes Thermostable enzymes used in the manufacture of diagnostic kits and reagents.
- Excipients Superior quality excipients for the pharmaceutical industry, including products like butylhydroxytoluene.
- Fine chemicals Essential chemical substances for numerous applications in scientific and industrial contexts.
- Nucleic acids and derivatives Collection of nucleic acids and similar products including DNA, RNA, and related compounds.
- Organic synthesis products Intermediates, catalysts, and building blocks for organic synthesis reactions.
- Stains & Indicators Dyes and indicators for diagnostic and analytical applications, including products like crystal violet and malachite green.
- PharmaFine® product line A product line of pharmaceutical raw materials designed for assessment in parenteral applications, offering greater control for demanding pharmaceutical requirements.
Companies that use DC Fine Chemicals
Customer profileSegments1 record
Ideal customer profiles1 record
DC Fine Chemicals technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
DC Fine Chemicals partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
DC Fine Chemicals competitors and assessment
Company assessmentBroad incumbents
- Avantor (VWR): Avantor, which acquired VWR, is a global distributor of laboratory products, chemicals, and biopharma manufacturing materials. It overlaps heavily with DC Fine Chemicals' diagnostics and pharma customer base and offers broader logistics and procurement services.
- Sigma-Aldrich (MilliporeSigma): MilliporeSigma, the life science business of Merck KGaA, is the global leader in fine chemicals, reagents, and analytical standards. It serves as the dominant incumbent against which DC Fine Chemicals competes for pharma, diagnostic, and research customers.
- Honeywell Research Chemicals (formerly Fluka): Honeywell's Research Chemicals business (formerly Fluka, now part of Honeywell Specialty Chemicals) supplies analytical reagents and fine chemicals globally. It competes with DC Fine Chemicals in the analytical reagents and process solutions segments.
- Thermo Fisher Scientific (Alfa Aesar / Fisher Chemical): Thermo Fisher's chemical reagent brands (Alfa Aesar, Fisher Chemical, Acros Organics) cover inorganic, organic, and analytical reagents globally. As one of the largest players in fine chemicals distribution, it represents both a competitor and a benchmark for DC Fine Chemicals' scale ambitions.
Direct peers
- TCI Chemicals: TCI Chemicals is a Japan-based manufacturer and supplier of fine chemicals, organic synthesis reagents, and analytical standards serving research, pharma, and diagnostics customers globally. It is highly comparable to DC Fine Chemicals in product breadth, customer base, and distribution-led business model.
- Carl Roth: Carl Roth is a European manufacturer and distributor of fine chemicals, reagents, and life science consumables, headquartered in Germany. It directly mirrors DC Fine Chemicals' catalogue breadth, multilingual European presence, and focus on lab and pharma customers.
- Scharlab (Scharlau): Scharlab is a Spanish manufacturer of laboratory reagents, chemicals, and microbiology products headquartered near Barcelona. It is a geographic and product-line competitor to DC Fine Chemicals within the Iberian and broader European market.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology supplies biochemicals, antibodies, and lab reagents to life science researchers globally. While more life-science focused, it overlaps with DC Fine Chemicals' diagnostics and life science segments in amino acids, stains, and biological buffers.
- PanReac AppliChem (ITW Reagents): PanReac AppliChem is a Spanish-based manufacturer of reagents, chemicals, and lab products, now part of ITW Reagents. It is a strong direct competitor to DC Fine Chemicals in its home Iberian market and across European pharma and lab customers.
Emerging players
- Biosynth: Biosynth is a specialty manufacturer and supplier of chemicals, peptides, and diagnostics substrates, with a growing focus on life science and pharma customers. It is an emerging mid-market peer that overlaps with DC Fine Chemicals in diagnostics reagents and amino acids.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
DC Fine Chemicals compliance and trust
Trust signalCompliance8 records
DC Fine Chemicals financial estimates
Financial estimateRevenue estimate
Valuation estimate
DC Fine Chemicals leadership team
Management profileNumber of profiles
Profiles15 records
DC Fine Chemicals funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DC Fine Chemicals M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DC Fine Chemicals
What does DC Fine Chemicals do?
DC Fine Chemicals manufactures and supplies a catalogue of 3,000+ reference fine chemical products (including APIs, excipients, amino acids, analytical reagents, bile acids, biological buffers, carbohydrates, enzymes, nucleic acids, organic synthesis intermediates, and stains & indicators) to pharmaceutical, diagnostic, life science, biotech, and industrial customers in 40+ countries. The company sources through a global supplier network giving access to 10,000+ substances and provides in-house quality control, Certificate of Analysis, custom packaging, and OEM services from facilities in Terrassa, Spain and London, United Kingdom.
Is DC Fine Chemicals a public or private company?
DC Fine Chemicals is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was DC Fine Chemicals founded?
DC Fine Chemicals was founded in 2007. It employs 51 to 100 people.
Where is DC Fine Chemicals based?
DC Fine Chemicals is headquartered in Cornellá De Llobregat, Spain, in the Europe region.
How does DC Fine Chemicals make money?
One revenue line is on record: fine Chemicals Distribution.
Who are DC Fine Chemicals's main competitors?
Broad incumbents on record are Avantor (VWR), Sigma-Aldrich (MilliporeSigma), Honeywell Research Chemicals (formerly Fluka) and Thermo Fisher Scientific (Alfa Aesar / Fisher Chemical). Direct peers are TCI Chemicals, Carl Roth, Scharlab (Scharlau), Santa Cruz Biotechnology and PanReac AppliChem (ITW Reagents). Biosynth is listed as an emerging player.
Does DC Fine Chemicals have an API?
No public API is recorded for DC Fine Chemicals.